Tandem Diabetes Is Worth Keeping An Eye On

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States.

Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces. Insulin is a hormone that regulates blood sugar. Hyperglycaemia, or raised blood sugar, is a common effect of uncontrolled diabetes and over time leads to serious damage to many of the body’s systems, especially the nerves and blood vessels

More than 100 million U.S. adults are now living with diabetes or prediabetes, according to a new report released today by the Centers for Disease Control and Prevention (CDC). The report finds that as of 2015, 30.3 million Americans – 9.4 percent of the U.S. population –have diabetes. Another 84.1 million have prediabetes, a condition that if not treated often leads to type 2 diabetes within five years.


The company’s flagship product is the t:slim X2 insulin delivery system that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 Insulin Delivery System with Basal-IQ Technology; t:slim X2 with G5 Integration; and Tandem Device Updater that allows users to update their pump’s software

Tandem’s t:slim X2 is the smallest durable insulin pump on the market at present and is the only pump in the US market that offers remote software updates. Also, the insulin pump integrates with Dexcom’s G6 continuous glucose monitoring (CGM) system, is the first automated insulin-delivery system approved for use in children as young as six years old.

Tandem Diabetes Care (TNDM) also sells disposable products that are used together with pumps and are replaced every few days.These disposable products are great because they produce reoccurring revenue (think of the disposable razors for the Gillette razor blade…which I hate buying because I know they are overpriced).

Since 2012,Tandem has sold over 72,000 pumps in the US, but 63,000 pumps have been sold in the last four years. In addition, Tandem is also going international to capture opportunities after Johnson & Johnson’s exit from the insulin pump market. This is good because Tandem has penetrated less than 1% of the total addressable diabetes market worldwide.

In recent weeks, Tandem attained Health Canada approval for the t:slim X2 insulin pump with Basal-IQ technology. This approval is expected to accelerate Tandem Diabetes’ global pump shipments and expand its customer base.

But just the other day, Tandem got better news.

Tandem Diabetes (TNDM) nabbed Food and Drug Administration clearance for a new diabetes management system Friday — prodding TNDM stock to pop midday.

The FDA cleared a diabetes management system dubbed Control-IQ to work with Tandem’s insulin pump, dubbed t:slim X2. The closed loop system works with Dexcom’s (DXCM) continuous glucose monitor. The devices automatically adjust insulin to prevent high and low blood sugar.

With the clearance, the FDA also created a new category for interoperable medical devices, known as an automated insulin dosing system. This diabetes management system has the potential to rival devices from Medtronic (MDT).


The potential to take on Medtronic is a big deal as Medtronic is the 800 lb gorilla in the room. One should keep Tandem on their radar screen and the levels to pay attention to are the weekly zones near $80 and near $45.

This post is my personal opinion. I’m not a financial advisor, this isn’t financial advise. Do your own research before making investment decisions.

The Sunday Crypto Recap – Down the Rabbit Hole 59

Overall, the charts look set in their bearish ways. A Christmas rally seems increasingly unlikely. Thankfully, there are plenty of other areas worth focusing on from central banks announcing plans to roll out their own versions of crypto to China’s daily expansion into blockchain. This week’s recap focuses, in particular, on the Chinese Communist Parties ‘plans’ for the cryptosphere.

Picks of the Week

This report on the current state of play of blockchain in China. This podcast wrapping up a 5 part series on the same topic and this article examining the CCP’s ’embrace of blockchain’ but evident antipathy towards Bitcoin.


This BTC thing will never catch-on:

A perspective on why BTC price lags apparent interest:

BTC halving likely to lead to a price rise?:

Over a thousand companies in Hainan province alone are in
some way engaged with blockchain:

On EOS achievements to date:

China’s embrace of blockchain is neither benign or destined to succeed:

Peer to peer cash – why its hard to achieve ad why it matters (highly recommended):

Gold and yields showing remarkable divergence:


BTC is not failing:

Is BTC really deflationary?:

China ‘loves’ blockchain but ‘dislikes’ BTC – so why is that? (recommended):

BTC halving impact will have minimal market effect:

Is BTC in its ‘chasm phase’? (highly recommended):

The complex reality of Altcoin tokenomics (recommended):

A report on one of the first EOS blockchain games (recommended):

Excellent overview of the current state of the blockchain industry in China (leads to a link to download the report – highly recommended):

HEX is a clever scam but a scam nonetheless:


Deciphering China’s role in blockchain – Part 5 of 5 (highly recommended):



A good overview of possible trends for crypto 2020:

BTC’s ROI is decreasing each cycle but still impressive:

Anton Antonopoulos on EOS (highly recommended):

REX is back up and running + a little context on DAPP costs (recommended):

Colin shares his views on a wide range of crypto topics:


Whose buying BTC (on Localbitcoins):


A useful visual guide to the main forks BTC soft/hard over the years:


It’s been a heck of a run for equities:


Website / Utility

Useful website for researching DeFi projects:


Lots to take-in. As always looking forward to your comments and suggestions.

Note on Sources:

Twitter & Reddit (cryptos current meta-brains) / Medium / Trybe / Hackernoon / Whaleshares / TIMM and so on/ YouTube / various podcasts and whatever else I stumble upon. The aim is a useful weekly aggregator of ideas rather than news. Though I try to keep the sources current – I’ll reference these articles and podcasts etc. as I encounter them – they may have been published just a couple of days ago or in some cases quite a bit earlier.